• 855-853-4760
  • customerservice@arevapharma.com

Pamidronate

Pamidronate

Pamidronate Disodium Injection is a bone-resorption inhibitor indicated for the treatment of hypercalcemia associated with malignancy, for Paget’s disease, and for the osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma.

STORAGE CONDITIONS Pamidronate disodium should be stored at room temperature, but not to exceed 86° F NOT A REFRIGERATED PRODUCT; Expiration Dating is 24 months.

PREPARATION OF SOLUTION: Reconstitution – Pamidronate disodium for Injection USP is reconstituted by adding 10 mL of Sterile Water for Injection, USP, to each vial, resulting in a solution of 30 mg/10 mL, 60mg/10mL or 90 mg/10 mL. The pH of the reconstituted solution is 6.0-7.4. The drug should be completely dissolved before the solution is withdrawn. The reconstituted solution may be stored under refrigeration at 2°C-8°C (36°F-46°F) for up to 24 hours.

Products Infomation
RX PRODUCT NDC# STRENGTH SIZE PRODUCT CLASS ADMINISTRATION CASE SIZE
Pamidronate Disodium Injection 59923-601-10 30 mg of sterile, lyophilized pamidronate disodium and 470 mg of mannitol, USP 30 mg vial chemotherapeutic-adjunct IV 100 vials
Pamidronate Disodium Injection 59923-603-10 90 mg of sterile lyophilized pamidronate disodium and 375 mg of mannitol, USP 90 mg vial chemotherapeutic-adjunct IV 100 vials
Wholesaler Pamidronate 3mg/10ml Pamidronate 9mg/10ml
AmerisourceBergen 10140655 10140656
Cardinal 4942157 4942165
McKesson 2035558 2035541